ID   VPP3_HUMAN              Reviewed;         830 AA.
AC   Q13488; O75877; Q8WVC5;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   10-FEB-2009, sequence version 3.
DT   28-JUN-2023, entry version 207.
DE   RecName: Full=V-type proton ATPase 116 kDa subunit a 3;
DE            Short=V-ATPase 116 kDa subunit a 3;
DE   AltName: Full=Osteoclastic proton pump 116 kDa subunit;
DE            Short=OC-116 kDa;
DE            Short=OC116;
DE   AltName: Full=T-cell immune regulator 1;
DE   AltName: Full=T-cell immune response cDNA7 protein;
DE            Short=TIRC7;
DE   AltName: Full=Vacuolar proton translocating ATPase 116 kDa subunit a isoform 3;
GN   Name=TCIRG1; Synonyms=ATP6N1C, ATP6V0A3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM LONG).
RC   TISSUE=Osteoclastoma;
RX   PubMed=8579597; DOI=10.1006/bbrc.1996.0145;
RA   Li Y.P., Chen W., Stashenko P.;
RT   "Molecular cloning and characterization of a putative novel human
RT   osteoclast-specific 116-kDa vacuolar proton pump subunit.";
RL   Biochem. Biophys. Res. Commun. 218:813-821(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM SHORT).
RA   Utku N., Heinemann T., Bulwin C.-G., Beinke S., Beato F., Randall J.,
RA   Busconi L., Delphire E., Robertson E.R., Kojima R., Volk H.D.,
RA   Milford E.L., Gullans S.R.;
RL   Submitted (SEP-1997) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM SHORT), AND FUNCTION.
RX   PubMed=10329006; DOI=10.1006/geno.1999.5751;
RA   Heinemann T., Bulwin G.C., Randall J., Schnieders B., Sandhoff K.,
RA   Volk H.D., Milford E., Gullans S.R., Utku N.;
RT   "Genomic organization of the gene coding for TIRC7, a novel membrane
RT   protein essential for T cell activation.";
RL   Genomics 57:398-406(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM LONG).
RC   TISSUE=Lung, and Pancreas;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   VARIANTS OPTB1 ARG-405 AND LEU-444.
RX   PubMed=11532986; DOI=10.1093/hmg/10.17.1767;
RA   Sobacchi C., Frattini A., Orchard P., Porras O., Tezcan I., Andolina M.,
RA   Babul-Hirji R., Baric I., Canham N., Chitayat D., Dupuis-Girod S.,
RA   Ellis I., Etzioni A., Fasth A., Fisher A., Gerritsen B., Gulino V.,
RA   Horwitz E., Klamroth V., Lanino E., Mirolo M., Musio A., Matthijs G.,
RA   Nonomaya S., Notarangelo L.D., Ochs H.D., Superti-Furga A., Valiaho J.,
RA   van Hove J.L.K., Vihinen M., Vujic D., Vezzoni P., Villa A.;
RT   "The mutational spectrum of human malignant autosomal recessive
RT   osteopetrosis.";
RL   Hum. Mol. Genet. 10:1767-1773(2001).
RN   [7]
RP   VARIANT OPTB1 ARG-405.
RX   PubMed=12552563; DOI=10.1002/humu.10165;
RA   Scimeca J.-C., Quincey D., Parrinello H., Romatet D., Grosgeorge J.,
RA   Gaudray P., Philip N., Fischer A., Carle G.F.;
RT   "Novel mutations in the TCIRG1 gene encoding the a3 subunit of the vacuolar
RT   proton pump in patients affected by infantile malignant osteopetrosis.";
RL   Hum. Mutat. 21:151-157(2003).
RN   [8]
RP   VARIANTS OPTB1 PRO-141; ARG-405; ASN-462 DEL; ASN-517 AND ARG-775.
RX   PubMed=15300850; DOI=10.1002/humu.20076;
RA   Susani L., Pangrazio A., Sobacchi C., Taranta A., Mortier G.,
RA   Savarirayan R., Villa A., Orchard P., Vezzoni P., Albertini A.,
RA   Frattini A., Pagani F.;
RT   "TCIRG1-dependent recessive osteopetrosis: mutation analysis, functional
RT   identification of the splicing defects, and in vitro rescue by U1 snRNA.";
RL   Hum. Mutat. 24:225-235(2004).
CC   -!- FUNCTION: Subunit of the V0 complex of vacuolar(H+)-ATPase (V-ATPase),
CC       a multisubunit enzyme composed of a peripheral complex (V1) that
CC       hydrolyzes ATP and a membrane integral complex (V0) that translocates
CC       protons (By similarity). V-ATPase is responsible for acidifying and
CC       maintaining the pH of intracellular compartments and in some cell
CC       types, is targeted to the plasma membrane, where it is responsible for
CC       acidifying the extracellular environment (By similarity). Seems to be
CC       directly involved in T-cell activation (PubMed:10329006).
CC       {ECO:0000250|UniProtKB:Q29466, ECO:0000250|UniProtKB:Q93050,
CC       ECO:0000269|PubMed:10329006}.
CC   -!- SUBUNIT: V-ATPase is a heteromultimeric enzyme made up of two
CC       complexes: the ATP-hydrolytic V1 complex and the proton translocation
CC       V0 complex (By similarity). The V1 complex consists of three catalytic
CC       AB heterodimers that form a heterohexamer, three peripheral stalks each
CC       consisting of EG heterodimers, one central rotor including subunits D
CC       and F, and the regulatory subunits C and H (By similarity). The proton
CC       translocation complex V0 consists of the proton transport subunit a, a
CC       ring of proteolipid subunits c9c'', rotary subunit d, subunits e and f,
CC       and the accessory subunits ATP6AP1/Ac45 and ATP6AP2/PRR (By
CC       similarity). {ECO:0000250|UniProtKB:Q93050}.
CC   -!- INTERACTION:
CC       Q13488; Q7Z3K3: POGZ; NbExp=3; IntAct=EBI-3914669, EBI-1389308;
CC       Q13488; O43711: TLX3; NbExp=3; IntAct=EBI-3914669, EBI-3939165;
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000250}; Multi-pass membrane
CC       protein {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=Long;
CC         IsoId=Q13488-1; Sequence=Displayed;
CC       Name=Short;
CC         IsoId=Q13488-2; Sequence=VSP_000345;
CC   -!- TISSUE SPECIFICITY: Isoform long is highly expressed in osteoclastomas.
CC       Isoform short is highly expressed in thymus.
CC   -!- DISEASE: Osteopetrosis, autosomal recessive 1 (OPTB1) [MIM:259700]: A
CC       rare genetic disease characterized by abnormally dense bone, due to
CC       defective resorption of immature bone. Osteopetrosis occurs in two
CC       forms: a severe autosomal recessive form occurring in utero, infancy,
CC       or childhood, and a benign autosomal dominant form occurring in
CC       adolescence or adulthood. Recessive osteopetrosis commonly manifests in
CC       early infancy with macrocephaly, feeding difficulties, evolving
CC       blindness and deafness, bone marrow failure, severe anemia, and
CC       hepatosplenomegaly. Deafness and blindness are generally thought to
CC       represent effects of pressure on nerves. {ECO:0000269|PubMed:11532986,
CC       ECO:0000269|PubMed:12552563, ECO:0000269|PubMed:15300850}. Note=The
CC       disease is caused by variants affecting the gene represented in this
CC       entry.
CC   -!- SIMILARITY: Belongs to the V-ATPase 116 kDa subunit family.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=TCIRG1base; Note=TCIRG1 mutation db;
CC       URL="http://structure.bmc.lu.se/idbase/TCIRG1base/";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U45285; AAA97878.1; -; mRNA.
DR   EMBL; AF025374; AAC35742.1; -; mRNA.
DR   EMBL; AF033033; AAD31081.2; -; Genomic_DNA.
DR   EMBL; CH471076; EAW74691.1; -; Genomic_DNA.
DR   EMBL; BC018133; AAH18133.1; -; mRNA.
DR   EMBL; BC032465; AAH32465.1; -; mRNA.
DR   CCDS; CCDS53670.1; -. [Q13488-2]
DR   CCDS; CCDS8177.1; -. [Q13488-1]
DR   RefSeq; NP_006010.2; NM_006019.3. [Q13488-1]
DR   RefSeq; NP_006044.1; NM_006053.3. [Q13488-2]
DR   RefSeq; XP_005273766.1; XM_005273709.3.
DR   RefSeq; XP_011543028.1; XM_011544726.2.
DR   AlphaFoldDB; Q13488; -.
DR   SMR; Q13488; -.
DR   BioGRID; 115597; 82.
DR   ComplexPortal; CPX-6905; Vacuolar proton translocating ATPase complex, ATP6V0A3 variant.
DR   IntAct; Q13488; 16.
DR   MINT; Q13488; -.
DR   STRING; 9606.ENSP00000265686; -.
DR   DrugBank; DB01133; Tiludronic acid.
DR   DrugCentral; Q13488; -.
DR   GlyGen; Q13488; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q13488; -.
DR   PhosphoSitePlus; Q13488; -.
DR   SwissPalm; Q13488; -.
DR   BioMuta; TCIRG1; -.
DR   DMDM; 223634720; -.
DR   EPD; Q13488; -.
DR   jPOST; Q13488; -.
DR   MassIVE; Q13488; -.
DR   MaxQB; Q13488; -.
DR   PaxDb; Q13488; -.
DR   PeptideAtlas; Q13488; -.
DR   ProteomicsDB; 59481; -. [Q13488-1]
DR   ProteomicsDB; 59482; -. [Q13488-2]
DR   Antibodypedia; 30523; 119 antibodies from 28 providers.
DR   DNASU; 10312; -.
DR   Ensembl; ENST00000265686.8; ENSP00000265686.3; ENSG00000110719.11. [Q13488-1]
DR   Ensembl; ENST00000532635.5; ENSP00000434407.1; ENSG00000110719.11. [Q13488-2]
DR   GeneID; 10312; -.
DR   KEGG; hsa:10312; -.
DR   MANE-Select; ENST00000265686.8; ENSP00000265686.3; NM_006019.4; NP_006010.2.
DR   UCSC; uc001one.4; human. [Q13488-1]
DR   AGR; HGNC:11647; -.
DR   CTD; 10312; -.
DR   DisGeNET; 10312; -.
DR   GeneCards; TCIRG1; -.
DR   HGNC; HGNC:11647; TCIRG1.
DR   HPA; ENSG00000110719; Tissue enhanced (pancreas).
DR   MalaCards; TCIRG1; -.
DR   MIM; 259700; phenotype.
DR   MIM; 604592; gene.
DR   neXtProt; NX_Q13488; -.
DR   OpenTargets; ENSG00000110719; -.
DR   Orphanet; 486; Autosomal dominant severe congenital neutropenia.
DR   Orphanet; 667; Autosomal recessive malignant osteopetrosis.
DR   Orphanet; 1782; Dysosteosclerosis.
DR   Orphanet; 210110; Intermediate osteopetrosis.
DR   PharmGKB; PA36399; -.
DR   VEuPathDB; HostDB:ENSG00000110719; -.
DR   eggNOG; KOG2189; Eukaryota.
DR   GeneTree; ENSGT00950000182881; -.
DR   HOGENOM; CLU_005230_0_0_1; -.
DR   InParanoid; Q13488; -.
DR   OMA; SKIVKIC; -.
DR   OrthoDB; 1967517at2759; -.
DR   PhylomeDB; Q13488; -.
DR   TreeFam; TF300346; -.
DR   BioCyc; MetaCyc:ENSG00000110719-MON; -.
DR   PathwayCommons; Q13488; -.
DR   Reactome; R-HSA-1222556; ROS and RNS production in phagocytes.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   Reactome; R-HSA-77387; Insulin receptor recycling.
DR   Reactome; R-HSA-917977; Transferrin endocytosis and recycling.
DR   Reactome; R-HSA-9639288; Amino acids regulate mTORC1.
DR   Reactome; R-HSA-983712; Ion channel transport.
DR   SignaLink; Q13488; -.
DR   BioGRID-ORCS; 10312; 16 hits in 1154 CRISPR screens.
DR   ChiTaRS; TCIRG1; human.
DR   GeneWiki; TCIRG1; -.
DR   GenomeRNAi; 10312; -.
DR   Pharos; Q13488; Tbio.
DR   PRO; PR:Q13488; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   RNAct; Q13488; protein.
DR   Bgee; ENSG00000110719; Expressed in granulocyte and 97 other tissues.
DR   ExpressionAtlas; Q13488; baseline and differential.
DR   Genevisible; Q13488; HS.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:UniProtKB.
DR   GO; GO:0010008; C:endosome membrane; TAS:Reactome.
DR   GO; GO:0101003; C:ficolin-1-rich granule membrane; TAS:Reactome.
DR   GO; GO:0005770; C:late endosome; IEA:Ensembl.
DR   GO; GO:0005765; C:lysosomal membrane; HDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IEA:Ensembl.
DR   GO; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0033176; C:proton-transporting V-type ATPase complex; NAS:ComplexPortal.
DR   GO; GO:0016471; C:vacuolar proton-transporting V-type ATPase complex; IBA:GO_Central.
DR   GO; GO:0000220; C:vacuolar proton-transporting V-type ATPase, V0 domain; IEA:InterPro.
DR   GO; GO:0051117; F:ATPase binding; IBA:GO_Central.
DR   GO; GO:0046961; F:proton-transporting ATPase activity, rotational mechanism; TAS:ProtInc.
DR   GO; GO:0006915; P:apoptotic process; IEA:Ensembl.
DR   GO; GO:0000045; P:autophagosome assembly; IEA:Ensembl.
DR   GO; GO:0030183; P:B cell differentiation; IEA:Ensembl.
DR   GO; GO:0045453; P:bone resorption; IEA:Ensembl.
DR   GO; GO:0006968; P:cellular defense response; TAS:ProtInc.
DR   GO; GO:0071345; P:cellular response to cytokine stimulus; IEA:Ensembl.
DR   GO; GO:0097188; P:dentin mineralization; IEA:Ensembl.
DR   GO; GO:0070166; P:enamel mineralization; IEA:Ensembl.
DR   GO; GO:0030010; P:establishment of cell polarity; IEA:Ensembl.
DR   GO; GO:0051650; P:establishment of vesicle localization; IEA:Ensembl.
DR   GO; GO:0010467; P:gene expression; IEA:Ensembl.
DR   GO; GO:0061484; P:hematopoietic stem cell homeostasis; IEA:Ensembl.
DR   GO; GO:0016064; P:immunoglobulin mediated immune response; IEA:Ensembl.
DR   GO; GO:0006954; P:inflammatory response; IEA:Ensembl.
DR   GO; GO:0006874; P:intracellular calcium ion homeostasis; IEA:Ensembl.
DR   GO; GO:0007042; P:lysosomal lumen acidification; NAS:ComplexPortal.
DR   GO; GO:0016236; P:macroautophagy; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0035709; P:memory T cell activation; IEA:Ensembl.
DR   GO; GO:0021554; P:optic nerve development; IEA:Ensembl.
DR   GO; GO:0001503; P:ossification; IEA:Ensembl.
DR   GO; GO:0030316; P:osteoclast differentiation; IEA:Ensembl.
DR   GO; GO:0002158; P:osteoclast proliferation; IEA:Ensembl.
DR   GO; GO:0045851; P:pH reduction; IEA:Ensembl.
DR   GO; GO:0090383; P:phagosome acidification; IEA:Ensembl.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; TAS:ProtInc.
DR   GO; GO:0007039; P:protein catabolic process in the vacuole; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0033365; P:protein localization to organelle; IEA:Ensembl.
DR   GO; GO:1902600; P:proton transmembrane transport; TAS:ProtInc.
DR   GO; GO:0010468; P:regulation of gene expression; IEA:Ensembl.
DR   GO; GO:0050796; P:regulation of insulin secretion; IEA:Ensembl.
DR   GO; GO:0045667; P:regulation of osteoblast differentiation; IEA:Ensembl.
DR   GO; GO:0010155; P:regulation of proton transport; IEA:Ensembl.
DR   GO; GO:0010272; P:response to silver ion; IEA:Ensembl.
DR   GO; GO:0060041; P:retina development in camera-type eye; IEA:Ensembl.
DR   GO; GO:0031529; P:ruffle organization; IEA:Ensembl.
DR   GO; GO:0030217; P:T cell differentiation; IEA:Ensembl.
DR   GO; GO:0043029; P:T cell homeostasis; IEA:Ensembl.
DR   GO; GO:0035711; P:T-helper 1 cell activation; IEA:Ensembl.
DR   GO; GO:0044691; P:tooth eruption; IEA:Ensembl.
DR   GO; GO:0007035; P:vacuolar acidification; IBA:GO_Central.
DR   InterPro; IPR002490; V-ATPase_116kDa_su.
DR   InterPro; IPR026028; V-type_ATPase_116kDa_su_euka.
DR   PANTHER; PTHR11629:SF21; V-TYPE PROTON ATPASE 116 KDA SUBUNIT A3; 1.
DR   PANTHER; PTHR11629; VACUOLAR PROTON ATPASES; 1.
DR   Pfam; PF01496; V_ATPase_I; 1.
DR   PIRSF; PIRSF001293; ATP6V0A1; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Disease variant; Hydrogen ion transport;
KW   Ion transport; Membrane; Osteopetrosis; Reference proteome; Transmembrane;
KW   Transmembrane helix; Transport.
FT   CHAIN           1..830
FT                   /note="V-type proton ATPase 116 kDa subunit a 3"
FT                   /id="PRO_0000119218"
FT   TOPO_DOM        1..385
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        386..404
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        405..406
FT                   /note="Vacuolar"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        407..423
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        424..438
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        439..468
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        469..532
FT                   /note="Vacuolar"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        533..552
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        553..570
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        571..591
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        592..635
FT                   /note="Vacuolar"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        636..655
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        656..720
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        721..745
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        746..766
FT                   /note="Vacuolar"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        767..807
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        808..830
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   REGION          139..158
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          681..701
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   VAR_SEQ         1..216
FT                   /note="Missing (in isoform Short)"
FT                   /evidence="ECO:0000303|Ref.2"
FT                   /id="VSP_000345"
FT   VARIANT         56
FT                   /note="R -> W (in dbSNP:rs36027301)"
FT                   /id="VAR_054340"
FT   VARIANT         141
FT                   /note="A -> P (in OPTB1)"
FT                   /evidence="ECO:0000269|PubMed:15300850"
FT                   /id="VAR_020988"
FT   VARIANT         161
FT                   /note="P -> L (in dbSNP:rs34227834)"
FT                   /id="VAR_054341"
FT   VARIANT         405
FT                   /note="G -> R (in OPTB1; dbSNP:rs137853150)"
FT                   /evidence="ECO:0000269|PubMed:11532986,
FT                   ECO:0000269|PubMed:12552563, ECO:0000269|PubMed:15300850"
FT                   /id="VAR_019569"
FT   VARIANT         444
FT                   /note="R -> L (in OPTB1; dbSNP:rs137853151)"
FT                   /evidence="ECO:0000269|PubMed:11532986"
FT                   /id="VAR_019570"
FT   VARIANT         462
FT                   /note="Missing (in OPTB1; dbSNP:rs771271907)"
FT                   /evidence="ECO:0000269|PubMed:15300850"
FT                   /id="VAR_020989"
FT   VARIANT         517
FT                   /note="D -> N (in OPTB1; dbSNP:rs369264588)"
FT                   /evidence="ECO:0000269|PubMed:15300850"
FT                   /id="VAR_020990"
FT   VARIANT         775
FT                   /note="P -> R (in OPTB1)"
FT                   /evidence="ECO:0000269|PubMed:15300850"
FT                   /id="VAR_020991"
FT   CONFLICT        377
FT                   /note="A -> R (in Ref. 1; AAA97878)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        603
FT                   /note="Missing (in Ref. 1; AAA97878)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   830 AA;  92968 MW;  50751B41B171D9D2 CRC64;
     MGSMFRSEEV ALVQLFLPTA AAYTCVSRLG ELGLVEFRDL NASVSAFQRR FVVDVRRCEE
     LEKTFTFLQE EVRRAGLVLP PPKGRLPAPP PRDLLRIQEE TERLAQELRD VRGNQQALRA
     QLHQLQLHAA VLRQGHEPQL AAAHTDGASE RTPLLQAPGG PHQDLRVNFV AGAVEPHKAP
     ALERLLWRAC RGFLIASFRE LEQPLEHPVT GEPATWMTFL ISYWGEQIGQ KIRKITDCFH
     CHVFPFLQQE EARLGALQQL QQQSQELQEV LGETERFLSQ VLGRVLQLLP PGQVQVHKMK
     AVYLALNQCS VSTTHKCLIA EAWCSVRDLP ALQEALRDSS MEEGVSAVAH RIPCRDMPPT
     LIRTNRFTAS FQGIVDAYGV GRYQEVNPAP YTIITFPFLF AVMFGDVGHG LLMFLFALAM
     VLAENRPAVK AAQNEIWQTF FRGRYLLLLM GLFSIYTGFI YNECFSRATS IFPSGWSVAA
     MANQSGWSDA FLAQHTMLTL DPNVTGVFLG PYPFGIDPIW SLAANHLSFL NSFKMKMSVI
     LGVVHMAFGV VLGVFNHVHF GQRHRLLLET LPELTFLLGL FGYLVFLVIY KWLCVWAARA
     ASAPSILIHF INMFLFSHSP SNRLLYPRQE VVQATLVVLA LAMVPILLLG TPLHLLHRHR
     RRLRRRPADR QEENKAGLLD LPDASVNGWS SDEEKAGGLD DEEEAELVPS EVLMHQAIHT
     IEFCLGCVSN TASYLRLWAL SLAHAQLSEV LWAMVMRIGL GLGREVGVAA VVLVPIFAAF
     AVMTVAILLV MEGLSAFLHA LRLHWVEFQN KFYSGTGYKL SPFTFAATDD
//
